These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29661138)

  • 1. A Coxiella burnetii phospholipase A homolog pldA is required for optimal growth in macrophages and developmental form lipid remodeling.
    Stead CM; Cockrell DC; Beare PA; Miller HE; Heinzen RA
    BMC Microbiol; 2018 Apr; 18(1):33. PubMed ID: 29661138
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Moormeier DE; Sandoz KM; Beare PA; Sturdevant DE; Nair V; Cockrell DC; Miller HE; Heinzen RA
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30745369
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid A Has Significance for Optimal Growth of
    Wang T; Yu Y; Liang X; Luo S; He Z; Sun Z; Jiang Y; Omsland A; Zhou P; Song L
    Front Cell Infect Microbiol; 2018; 8():192. PubMed ID: 29938202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Profiling of Coxiella burnetii Reveals Extensive Cell Wall Remodeling in the Small Cell Variant Developmental Form.
    Sandoz KM; Popham DL; Beare PA; Sturdevant DE; Hansen B; Nair V; Heinzen RA
    PLoS One; 2016; 11(2):e0149957. PubMed ID: 26909555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CsrA-Binding,
    Wachter S; Bonazzi M; Shifflett K; Moses AS; Raghavan R; Minnick MF
    J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31451541
    [No Abstract]   [Full Text] [Related]  

  • 6. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.
    Beare PA; Gilk SD; Larson CL; Hill J; Stead CM; Omsland A; Cockrell DC; Howe D; Voth DE; Heinzen RA
    mBio; 2011; 2(4):e00175-11. PubMed ID: 21862628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    May KL; Silhavy TJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29559571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.
    Larson CL; Beare PA; Voth DE; Howe D; Cockrell DC; Bastidas RJ; Valdivia RH; Heinzen RA
    Infect Immun; 2015 Feb; 83(2):661-70. PubMed ID: 25422265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.
    Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE
    Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii.
    Varghees S; Kiss K; Frans G; Braha O; Samuel JE
    Infect Immun; 2002 Dec; 70(12):6741-50. PubMed ID: 12438349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular life of Coxiella burnetii in macrophages.
    Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
    Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Murine Macrophages as a Tool for Virulence Factor Discovery in Coxiella burnetii.
    Case EDR; Mahapatra S; Hoffpauir CT; Konganti K; Hillhouse AE; Samuel JE; Van Schaik EJ
    Microbiol Spectr; 2022 Aug; 10(4):e0248421. PubMed ID: 35913176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxiella burnetii: international pathogen of mystery.
    Dragan AL; Voth DE
    Microbes Infect; 2020 Apr; 22(3):100-110. PubMed ID: 31574310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of an HtrA Sheddase Produced by
    Osman IO; Caputo A; Pinault L; Mege JL; Levasseur A; Devaux CA
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncanonical Inhibition of mTORC1 by Coxiella burnetii Promotes Replication within a Phagolysosome-Like Vacuole.
    Larson CL; Sandoz KM; Cockrell DC; Heinzen RA
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a stress-induced alternate sigma factor, RpoS, of Coxiella burnetii and its expression during the development cycle.
    Seshadri R; Samuel JE
    Infect Immun; 2001 Aug; 69(8):4874-83. PubMed ID: 11447163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited role for iron regulation in Coxiella burnetii pathogenesis.
    Briggs HL; Pul N; Seshadri R; Wilson MJ; Tersteeg C; Russell-Lodrigue KE; Andoh M; Bäumler AJ; Samuel JE
    Infect Immun; 2008 May; 76(5):2189-201. PubMed ID: 18316381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental transitions of Coxiella burnetii grown in axenic media.
    Sandoz KM; Sturdevant DE; Hansen B; Heinzen RA
    J Microbiol Methods; 2014 Jan; 96():104-10. PubMed ID: 24286928
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bitew MA; Khoo CA; Neha N; De Souza DP; Tull D; Wawegama NK; Newton HJ; Sansom FM
    J Biol Chem; 2018 Nov; 293(48):18636-18645. PubMed ID: 30315113
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.
    Fullerton MS; Colonne PM; Dragan AL; Brann KR; Kurten RC; Voth DE
    mSphere; 2021 Aug; 6(4):e0044221. PubMed ID: 34232075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.